The US Food and Drug Administration issued an emergency use authorization for the use of convalescent plasma to treat Covid 19 on Sunday , saying the " known and potential benefits of the product outweigh the known and potential risks of the product . " 
The FDA said more than 70,000 patients had been treated with convalescent plasma , made using the blood of people who have recovered from coronavirus infections . 
Last week , Trump accused some health officials of playing politics regarding an EUA for convalescent plasma . 
When asked about the FDA not having granted an EUA , Trump said the reason was political . 
On Sunday , a source who is close to the White House coronavirus task force told CNN the FDA had reviewed additional data to inform its impending EUA decision . 
This official has not personally reviewed the data . 
They added the FDA is under no obligation to consult anyone outside the agency about its decision . 
Convalescent plasma is taken from the blood of people who have recovered from Covid 19 . 
At the end of March , the FDA set up a pathway for scientists to try convalescent plasma with patients and study its impact . 
It has already been used to treat more than 60,000 Covid 19 patients . 
Read the full story : 
